Potential Anti-Vascular Endothelial Growth Factor Therapies for Central Retinal Vein Occlusion

Author： Figueroa Marta S.   Contreras Inés  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.16, 2012-11, pp. : 2063-2071

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapies directed at vascular endothelial growth factor

By Manley Paul W   Martiny-Baron Georg   Schlaeppi Jean-Marc   Wood Jeanette M  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1715-1736

Informa Healthcare

Access to resources Recommend Favorite

Clomifene: Central retinal vein occlusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1229, 2008-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 1000-1017

Bentham Science Publishers

Access to resources Recommend Favorite

Leuprorelin: First report of central retinal vein occlusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1184, 2008-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Primaquine: First report of central retinal vein occlusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite